R97.21
BillableRising PSA following treatment for malignant neoplasm of prostate
R97.21 is the ICD-10-CM code for Rising PSA following treatment for malignant neoplasm of prostate. It is a billable, specific code valid for reimbursement.
R00-R99 Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
What this means — in plain language
MedlinePlus · NIHLearn what a PSA test is, plus the limitations and potential harms of the test when used to screen for prostate cancer.
Read more about Prostate-Specific Antigen (PSA) Test at MedlinePlus ↗Source: U.S. National Library of Medicine (MedlinePlus). Informational only — not medical advice.
Conditions mapped to this code
MedlinePlus · NIHPlain-language health-topic references grounded in MedlinePlus (NIH/NLM).
Frequently asked questions
- What is ICD-10 code R97.21?
- R97.21 is the ICD-10-CM code for "Rising PSA following treatment for malignant neoplasm of prostate". It falls under R00-R99 Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified.
- Is R97.21 a billable code?
- Yes — R97.21 is a billable, specific ICD-10-CM code valid for reimbursement.
Source: CMS ICD-10-CM FY2026. For informational purposes only — not medical advice. See our medical disclaimer.
Look up another ICD-10 code or condition